Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2718998 | 0.91 | USP2 (0.39) | USP2SLCO1B1PDE4A | |
| SCHEMBL2558949 | 0.88 | USP2 (0.39) | USP2SLCO1B1PDE4A | |
| SCHEMBL3642844 | 0.88 | USP2 (0.39) | USP2SLCO1B1PDE4A | |
| SCHEMBL17201985 | 0.86 | USP2 (0.42) | USP2SLCO1B1PDE4A | |
| SCHEMBL2346239 | 0.84 | USP2 (0.36) | USP2SLCO1B1 | |
| SCHEMBL2723086 | 0.81 | USP2 (0.38) | USP2SLCO1B1 | |
| SCHEMBL11041165 | 0.76 | USP2 (0.39) | USP2SLCO1B1PDE4A | |
| SCHEMBL3628255 | 0.76 | USP2 (0.39) | USP2SLCO1B1PDE4A | |
| SCHEMBL3230568 | 0.76 | USP2 (0.39) | USP2SLCO1B1PDE4A | |
| SCHEMBL3227090 | 0.76 | USP2 (0.39) | USP2SLCO1B1PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1809758-A4 | IN VIVO SITE-SPECIFIC INCORPORATION OF N-ACETYL-GALACTOSAMINE AMINO ACIDS IN EUBACTERIA | SCRIPPS RESEARCH INST (US) | 2009-04-01 | — | — | EP | claimed |
| EP-1809758-A2 | IN VIVO SITE-SPECIFIC INCORPORATION OF N-ACETYL-GALACTOSAMINE AMINO ACIDS IN EUBACTERIA | The Scripps Research Institute (US) | 2007-07-25 | — | — | EP | claimed |
| WO-2006045116-A2 | IN VIVO SITE-SPECIFIC INCORPORATION OF N-ACETYL-GALACTOSAMINE AMINO ACIDS IN EUBACTERIA | THE SCRIPPS RESEARCH INSTITUTE (US) | 2006-04-27 | — | — | WO | claimed |
| WO-2024077277-A1 | DRUG LINKERS AND ANTIBODY CONJUGATES THEREOF | AMBRX, INC. (US) | 2024-04-11 | — | — | WO | disclosed |
| CN-105793241-B | Terpyridyl complex compound and its purposes in electrochromic applications based on metal | 耶达研究及发展有限公司 | 2019-06-18 | — | — | CN | disclosed |
| EP-2968552-A1 | TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF | The California Institute for Biomedical Research (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014153164-A1 | TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF | THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 2014-09-25 | — | — | WO | disclosed |
| EP-2640745-A2 | ANTIBODY DERIVATIVES | Allozyne, Inc. (US) | 2013-09-25 | — | — | EP | disclosed |
| WO-2012032181-A9 | ANTIBODY DERIVATIVES | ALLOZYNE, INC (US) | 2013-06-13 | — | — | WO | disclosed |
| WO-2012032181-A2 | NOVEL ANTIBODY DERIVATIVES | ALLOZYNE, INC (US) | 2012-03-15 | — | — | WO | disclosed |
| EP-1809758-A4 | IN VIVO SITE-SPECIFIC INCORPORATION OF N-ACETYL-GALACTOSAMINE AMINO ACIDS IN EUBACTERIA | SCRIPPS RESEARCH INST (US) | 2009-04-01 | — | — | EP | disclosed |
| EP-1809758-A2 | IN VIVO SITE-SPECIFIC INCORPORATION OF N-ACETYL-GALACTOSAMINE AMINO ACIDS IN EUBACTERIA | The Scripps Research Institute (US) | 2007-07-25 | — | — | EP | disclosed |
| WO-2006045116-A2 | IN VIVO SITE-SPECIFIC INCORPORATION OF N-ACETYL-GALACTOSAMINE AMINO ACIDS IN EUBACTERIA | THE SCRIPPS RESEARCH INSTITUTE (US) | 2006-04-27 | — | — | WO | disclosed |